Weinhoff Gregory M 4
4 · Centessa Pharmaceuticals plc · Filed Mar 13, 2026
Research Summary
AI-generated summary of this filing
Centessa (CNTA) CBO Gregory Weinhoff Sells Shares
What Happened
Gregory M. Weinhoff, Chief Business Officer of Centessa Pharmaceuticals plc (CNTA), sold a total of 73,196 ordinary shares (which may be represented by American Depositary Shares) in two open‑market transactions on March 13, 2026, generating approximately $1,927,131 in proceeds. The larger block was 61,253 shares at a weighted-average price of $26.17 (total $1,602,795); the smaller block was 11,943 shares at a weighted-average price of $27.16 (total $324,336). These were dispositions (sales), which are typically routine and not necessarily a signal about company prospects.
Key Details
- Transaction date: March 13, 2026 (filed same day).
- Sales: 61,253 shares @ weighted avg $26.17 (prices ranged $25.75–$26.70). 11,943 shares @ weighted avg $27.16 (prices ranged $26.805–$27.445).
- Total proceeds: ≈ $1,927,131.
- Shares owned after transaction: not disclosed in the provided filing details.
- Notable footnotes: sales were executed under a Rule 10b5-1 trading plan adopted Nov 12, 2025 (F2); ADS representation noted (each ADS currently represents one ordinary share) (F1). Weighted-average prices reported; the filer will provide per‑price breakdowns on request (F3, F4).
- Timeliness: Filing covers the March 13, 2026 transactions and was filed on the same date (no late filing indicated).
Context
- These were open-market sales under a pre-established 10b5-1 plan, a common mechanism insiders use to sell shares on a scheduled or automated basis. Such sales are routine and do not, by themselves, indicate insider sentiment about future company performance.
Insider Transaction Report
Form 4
Weinhoff Gregory M
Chief Business Officer
Transactions
- Sale
Ordinary Shares
[F1][F2][F3]2026-03-13$26.17/sh−61,253$1,602,795→ 77,868 total - Sale
Ordinary Shares
[F1][F2][F4]2026-03-13$27.16/sh−11,943$324,336→ 65,925 total
Footnotes (4)
- [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- [F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 12, 2025.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.75 to $26.70, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.805 to $27.445, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Signature
/s/ Raphael Deferiere, attorney-in-fact|2026-03-13